Journals / Göztepe Tıp Dergisi / 2003 / Cilt: 18 - Sayı: 4

Effect of hemodialysis and peritoneal dialysis on serum lipid profile in patients with chronic renal failure

Kronik böbrek yetersizlikli olgularda hemodiyaliz ve periton diyalizinin lipid profili üzerine etkisi

Pages
209–210
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that serum total cholesterol, LDL cholesterol and trygliseride levels are found higher in CAPD group than hemodialysis group, but the differences were not statistically significant.In conclusion the type of renal replacement therapy could effect the serum lipid profile and it seems that larger randomised controlled trials are needed to reply this question.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:One of the important reasons of cardiovascular mortality and morbidity in patients with chronic renal failure is the disturbed lipid metabolism.
📊
Key Findings & Data:Uremic lipidemia is charecterized by high or normal total cholesterol, low HDL cholesterol and high trygliseride levels.
💡
Conclusion & Impact:The results showed that serum total cholesterol, LDL cholesterol and trygliseride levels are found higher in CAPD group than hemodialysis group, but the differences were not statistically significant.In conclusion the type of renal replacement therapy could effect the serum lipid profile and it seems that larger randomised controlled trials are needed to reply this question.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

One of the important reasons of cardiovascular mortality and morbidity in patients with chronic renal failure is the disturbed lipid metabolism. Uremic lipidemia is charecterized by high or normal total cholesterol, low HDL cholesterol and high trygliseride levels. It is known that disturbances in serum lipid profile persist despite renal replacement therapy. The aim of this study is to assess the differences between the effect of hemodialysis and peritoneal dialysis on serum lipid profile.Patients, who were in the hemodialysis or CAPD program, were enrolled in the study. The results showed that serum total cholesterol, LDL cholesterol and trygliseride levels are found higher in CAPD group than hemodialysis group, but the differences were not statistically significant.In conclusion the type of renal replacement therapy could effect the serum lipid profile and it seems that larger randomised controlled trials are needed to reply this question.

Özet

Kronik böbrek yetersizlikli hastalarda kardiyovasküler mortalite ve morbititenin önemli nedenlerinden biri, bu hastalardaki lipid metabolizması bozukluğudur. Üremik dislipidemi yüksek veya normal total kolesterol, düşük HDL kolesterol ve yüksek trigliserid düzeyleri ile karakterizedir. Renal replasman tedavisi alan hastalarda da serum lipid profilindeki bozukluğun devam ettiği bilinmektedir. Bu çalışmanın amacı, hemodiyaliz ve periton diyalizinin serum lipid profili üzerine etkisini araştırmaktır.Hemodiyaliz ve SAPD programında olan hastalar çalışmaya dahil edildi.Sonuçlar SAPD grubunda hemodiyaliz grubuna göre serum total kolesterol, LDL kolesterol ve trigliserid düzeylerinin daha yüksek olduğunu gösterdi, fakat aradaki fark istatistiksel olarak anlamlı değildi.Sonuç olarak, renal replasman tedavisinin tipi lipid profilini etkileyebilir ve bu sorunun cevabını verebilmek için daha geniş randomize çalışmalara gereksinim vardır.

🔖

Cite This Article

KARADAYI, H., YALÇIN, Y., AKSOY, Z., CÜREBAL, F., OĞUZ, A. (2022). Effect of hemodialysis and peritoneal dialysis on serum lipid profile in patients with chronic renal failure. Göztepe Tıp Dergisi, Cilt: 18 - Sayı: 4, 209–210. https://ajindex.com/articles/526494

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Klahr, D'Amico G: Second International Symposium on lipids, Alherosiclerosis and the Kindey. Summary of scientific presentations. Nephrol Dial Transplant 9:1660-1663, 1994
  2. Tonelli M: Cardiac risk factors and the use of cardioprotecu've medications in patient with chronic renal insufficiency. Am J Kidney Dis 37(3):484-9,2001
  3. Attman PO, Alaupovic P: Lipid abnormalities in chronic renal insuffciency. Kidney Int39:16-23,1991
  4. Saltissi D: Effect of lipid-lowering dietary recommendations on the nutritional intake and lipid profiles of chronic peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 37(6):1209-l5,2001
  5. Bargman JM: Guidelines for adequacy and nutrition in peritoneal dialysis. Canadian Society of Nephrology. J Am Soc Nephrol 10 Suppl 13:311-21,1999
  6. D'Amico G, Gentile MG: Influence of diet on lipid abnormalities in human renal disease. Am J Kidney Dis 22:151-157,1993
  7. Johansson AC: Dyslipidemia in peritoneal dialysis—relation to dialytic variables. Pent Dial Int 20(3):306-14,2000
  8. Güz G: Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients. Am J Kidney Dis 36(4):826-36,2000
  9. Boffinger A, Westhuyzen J, SaWssi D, Morgan C, Healy H: Low-density lipoprotein subtraction profiles in patients with end-stage renal disease treated with haemodialysis or peritoneal dialysis. Nephrology 3:169-176,1997
  10. Grodstein GP, Kopple JD, Moran JK: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 19:564-567,1981
  11. Onat A, Şenocak M, ()rnek E, Gözükara Y, et al: Türkiye'de erişkinlerde kalp hastalığı ve risk faktörleri sıklığı taraması: 4. Kanda kolesterol ve trigliserid düzeyleri. Türk Kardiyol Dem Arş 19:169-177,1991
  12. Mahley RW, Palaoglu KE, Atak Z, Dawson- Pepin J, et al: Turkish Heart Study: lipids, lipoproteins, and apolipoprolciııs. J Lipid Res 36(4):839-59,1995.